Liver Cancer Treatment
Advanced minimally invasive therapies for primary liver cancer (HCC) and metastatic tumors.
Targeted Interventional Oncology for Liver Cancer
Liver cancer is highly vascular, making it an ideal candidate for targeted interventional radiology procedures. We offer tumor ablation, TACE, and TARE to treat cancer cells directly while sparing healthy liver tissue.
Understanding the Condition
Liver cancer can be primary (starting in the liver) or metastatic (spreading from other organs). Interventional oncology provides non-surgical alternatives for patients who may not be candidates for traditional surgery.
Common Symptoms
- Unexplained weight loss and loss of appetite
- Pain or swelling in the upper right abdomen
- Jaundice (yellowing of skin and eyes)
- Persistent fatigue and nausea
Risks of Ignoring
- Liver failure if untreated
- Risk of internal bleeding from portal hypertension
- Metastasis to other vital organs
- Loss of curative treatment window
Advanced Treatment Options
Tumor Ablation (RFA / MWA)
Uses thermal energy (heat) via a needle-probe to 'burn' smaller, localized tumors under ultrasound or CT guidance. Fast recovery and minimal scarring.
TACE (Trans-Arterial Chemo-Embolization)
Delivers high-dose chemotherapy directly to the tumor via a micro-catheter, followed by embolic particles to starve the tumor of nutrients and trap the drug inside.
TARE / Radioembolization (Y-90)
Delivers millions of microscopic radioactive beads (Y-90) through the blood supply to destroy the tumor with targeted radiation. Often better tolerated for larger tumors.
Key Benefits & Advantages
Targeted therapy spares healthy tissue
Minimally invasive 'pinhole' access
Shorter recovery than traditional surgery
Effective for non-surgical candidates
Can lead to significant tumor shrinkage
Book a Consultation
Schedule an appointment with our specialists to discuss if Liver Cancer Treatment is right for you.
